XML 14 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Changes in Mezzanine Equity and Stockholders' Equity - USD ($)
$ in Thousands
Total
Game Your Game
Game Your Game
Visualix
CXApp
Common Stock
Common Stock
Game Your Game
Common Stock
Visualix
Common Stock
CXApp
Additional Paid-In Capital
Additional Paid-In Capital
Game Your Game
Additional Paid-In Capital
Visualix
Additional Paid-In Capital
CXApp
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non-Controlling Interest
Non-Controlling Interest
Game Your Game
Series 7 Preferred Stock
Series 7 Preferred Stock
Additional Paid-In Capital
Series 4 Convertible Preferred Stock
Series 4 Convertible Preferred Stock
Preferred Stock
Series 5 Convertible Preferred Stock
Series 5 Convertible Preferred Stock
Preferred Stock
Series 8 Preferred Stock
Increase (Decrease) in Temporary Equity [Roll Forward]                                                  
Mezzanine equity, convertible preferred stock, shares outstanding (in shares)                                     0            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                  
Noncontrolling interest, ownership percentage by parent   55.40%                                              
Convertible preferred stock, beginning balance at Dec. 31, 2020                                     $ 0            
Increase (Decrease) in Temporary Equity [Roll Forward]                                                  
Series 7 and series 8 Preferred Stock issued for cash (in shares)                                     58,750            
Series 7 and series 8 Preferred Stock issued for cash                                     $ 46,034            
Series 7 Preferred Stock converted to common stock (in shares)                                     (9,500)            
Series 7 Preferred Stock converted to common stock                                     $ (9,500)            
Accrete Discount - Preferred Shares                                     $ 8,161            
Convertible preferred stock, ending balance (in shares) at Dec. 31, 2021                                     49,250           0
Convertible preferred stock, ending balance at Dec. 31, 2021                                     $ 44,695           $ 0
Balance, beginning (in shares) at Dec. 31, 2020                                           1   126  
Balance, beginning at Dec. 31, 2020 $ 44,680         $ 1       $ 225,665       $ (695) $ 660 $ (180,992) $ 41         $ 0   $ 0  
Balance, beginning (in shares) at Dec. 31, 2020           779,964                                      
Balance, beginning (in shares) at Dec. 31, 2020                           (1)                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                  
Shares issued for cash / offering 4,551                 4,551                              
Common shares issued for extinguishment of debt (in shares)           23,615                                      
Common shares issued for extinguishment of debt $ 2,500                 2,500                              
Common shares issued for cashless stock options exercised (in shares) 277         73                                      
Common shares issued for net proceeds from warrants exercised (in shares)           420,071                                      
Common shares issued for net proceeds from warrants exercised $ 3,779                 3,779                              
Stock options and restricted stock awards granted to employees and consultants for services 10,880                 10,880                              
Taxes paid on stock based compensation (1,858)                 (1,858)                              
Issuance of shares from acquisition (in shares)             15,722 4,928 117,995                                
Issuance of shares from acquisition     $ 3,875 $ 429 $ 10,000       $ 1   $ 1,403 $ 429 $ 9,999         $ 2,472              
Common shares issued for restricted stock grants (in shares)           62,308                                      
Common shares issued for restricted stock grants 0                 0                              
Series 7 Preferred Stock converted to common stock (in shares)           101,334                         9,500            
Series 7 Preferred Stock converted to common stock 9,500                 9,500                              
Accrete Discount - Preferred Shares (8,161)                 (8,161)                              
Restricted stock grants forfeited (in shares)           (6,538)                                      
Restricted stock grants forfeited 0                                                
Cumulative translation adjustment (628)                           (616) (162) 150                
Net income (loss) (70,130)                             (69,155) (975)                
Balance, ending (in shares) at Dec. 31, 2021                                         1 1 126 126  
Balance, ending at Dec. 31, 2021 $ 83,491         $ 2       332,761       $ (695) 44 (250,309) 1,688         $ 0   $ 0  
Balance, ending (in shares) at Dec. 31, 2021 1,730,140         1,730,140                                      
Balance, ending (in shares) at Dec. 31, 2021 (1)                         (1)                      
Increase (Decrease) in Temporary Equity [Roll Forward]                                                  
Mezzanine equity, convertible preferred stock, shares outstanding (in shares)                                     49,250           0
Series 7 and series 8 Preferred Stock issued for cash (in shares)                                                 53,198
Series 7 and series 8 Preferred Stock issued for cash                                                 $ 41,577
Accrete Discount - Preferred Shares                                     $ 4,555           13,090
Deemed dividend for the modification related to Series 8 Preferred Stock                                                 2,627
Deemed contribution for the modification related to warrants isued in connection with Series 8 Preferred Stock                                                 (1,469)
Amortization premium - modification related to Series 8 Preferred Stock                                                 $ (2,627)
Preferred stock redeemed for cash (in shares)                                     (49,250)           (53,198)
Preferred stock redeemed for cash                                     $ (49,250)           $ (53,198)
Convertible preferred stock, ending balance (in shares) at Dec. 31, 2022                                     0           0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                  
Shares issued for cash / offering $ 5,329                 5,329                              
Common shares issued for extinguishment of debt (in shares)           287,802                                      
Common shares issued for extinguishment of debt $ 3,650                 3,650                              
Common shares issued for cashless stock options exercised (in shares) 0                                                
Common shares issued for net proceeds from warrants exercised (in shares)           930,990                                      
Common shares issued for net proceeds from warrants exercised $ 1         $ 1                                      
Common shares issued for share rights (in shares) 52,513                                                
Stock options and restricted stock awards granted to employees and consultants for services $ 3,656                 3,656                              
Deemed contribution for the modification related to warrants isued in connection with Series 8 Preferred Stock 1,469                 1,469                              
Amortization premium - modification related to Series 8 Preferred Stock 2,627                 2,627                              
Restricted stock grants withheld for taxes (in shares)           (12,802)                                      
Taxes paid on stock based compensation (336)                 (336)                              
Issuance of shares from acquisition (in shares)           144,986                                      
Issuance of shares from acquisition 3,697                 3,697                              
Common shares issued for exchange of warrants (in shares)           184,153                                      
Accrete Discount - Preferred Shares (13,090)                 (13,090)                 $ (4,555) $ (4,555)          
Dividends, Preferred Stock, Cash (2,627)                 (2,627)                              
Cumulative translation adjustment 1,019                           1,017 (36) 38                
Net income (loss) (66,304)                             (63,394) (2,910)                
Balance, ending (in shares) at Dec. 31, 2022                                     0   1 1 126   0
Balance, ending at Dec. 31, 2022 $ 32,115         $ 4       $ 346,668       $ (695) $ 1,061 $ (313,739) $ (1,184)                
Balance, ending (in shares) at Dec. 31, 2022 3,570,893         3,570,894                                      
Balance, ending (in shares) at Dec. 31, 2022 (1)                         (1)                      
Increase (Decrease) in Temporary Equity [Roll Forward]                                                  
Mezzanine equity, convertible preferred stock, shares outstanding (in shares)                                     0           0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                  
Noncontrolling interest, ownership percentage by parent   55.40%